These findings suggest that cfDNA could be a valuable, non-invasive biomarker for clinicians to monitor colorectal cancer patients. Tracking cfDNA levels may help better evaluate surgical outcomes ...

The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising driver of the disease and other risk factors.

Lung cancer is the overall leading cause of cancer deaths across the nation. The American Cancer Society estimates that about 226,000 new cases of lung cancer will be diagnosed in 2025, and nearly ...

In the validation cohort, the eNose detected lung cancer in 72 of 121 (60%) participants, resulting in an ROC-AUC of 0.83, sensitivity of 94%, specificity of 63%, PPV of 79%, and NPV of 89%.

In 107 patients, 48.6% of those who received unusual or nonreportable clinical cfDNA-sequencing results had an occult cancer, reported Diana W. Bianchi, MD, of the Eunice Kennedy Shriver National ...

Despite years of warnings and a mountain of scientific evidence linking smoking to lung cancer, there remains one confounding question: Why do some smokers. Skip to content. News; ...

Learn about Galleri, the multi-cancer early detection blood test. Understand how it screens for 50+ cancers using cfDNA, its accuracy, cost, and limitations. News ...

Fresh data. For the study, published Wednesday in the New England Journal of Medicine, NIH researchers set out to repeat the cfDNA tests and then screen the women for cancer using various methods ...

Globally, more than 50% of women diagnosed with lung cancer are non-smokers, compared to 15% to 20% of men.Meanwhile, an estimated 57% of Asian-American women diagnosed with lung cancer have never ...

I was a runner and ‘never smoker’ — then I got diagnosed with lung cancer at 28 By . Tracy Swartz. Published May 16, 2025, 6:00 a.m. ET. Deep breath!